Dr. Francis C. Cordova, MD

Dr. Cordova practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Cordova's NPI, 1932197936, was assigned on October 12, 2005. Dr. Cordova holds Pennsylvania license MD049224L.

Dr. Cordova's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Cordova's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Cordova is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Cordova to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cordova practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Cordova's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Cordova is licensed in Pennsylvania.

CMS data shows 573 Medicare services from Dr. Cordova across 6 procedure codes in 2024, for 196 Medicare patients. Medicare paid $46,588 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 196 Medicare patients who saw Dr. Cordova in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have copd, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cordova's median patient age at 70, with 47% women.

In 2024, Dr. Cordova wrote 2,591 Medicare Part D claims for 211 patients. 67% of them were for generic drugs. CMS names the drug for 2,304 of them, across 44 drugs with 11 or more claims each, at $1,582,113 in total drug cost. In 2023, CMS named 1,486 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Cordova for performance year 2024, reported as part of a group. Dr. Cordova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Cordova, published from 2012 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Lung Transplantation, Hypertension, Pulmonary and Lung. Dr. Cordova has published most often in Respir Med. Dr. Cordova's most frequent co-authors are Yoshiya Toyoda, MD, PhD, Gerard Criner, MD and Albert James Mamary, MD.

Dmand AI links Dr. Cordova to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Bronchiolitis Obliterans Syndrome, Idiopathic Pulmonary Fibrosis and Organizing Pneumonia.

CMS Open Payments shows 32 general payments to Dr. Cordova from 5 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 52% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $6,699.